
Opinion|Videos|October 23, 2024 (Updated: October 16, 2024)
From Neuroplasticity to Patient Conversations: Managing Affective Disorders Effectively
Experts in affective disorders discuss the pathophysiology, genetic components, and neurocircuitry involved in these conditions. They delve into treatment nomenclature and patient conversations, focusing on how to target specific brain areas, assess responses, and manage treatments to improve quality of life and hedonic tone
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Experience With Xanomeline/Trospium in an Acute Inpatient Setting Treating Individuals With Schizophrenia
2
Home-Based tDCS for Depression: Expanding Access to Neuromodulation Treatment
3
FDA Approves Tauklarify (MK-6240) For Tau Pathology Detection in Alzheimer Disease
4
HLP003, Deuterated Psilocin, as an Adjunctive Therapy for Major Depressive Disorder
5







